INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ISRG - US46120E6023 - Common Stock
468.2 EUR
-35 (-6.96%)
We assign a fundamental rating of 6 out of 10 to 1ISRG. 1ISRG was compared to 68 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG shows excellent growth, but is valued quite expensive already. These ratings would make 1ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- In the past year 1ISRG was profitable.
- 1ISRG had a positive operating cash flow in the past year.
- Each year in the past 5 years 1ISRG has been profitable.
- 1ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 14.19%, 1ISRG belongs to the best of the industry, outperforming 92.65% of the companies in the same industry.
- 1ISRG's Return On Equity of 16.12% is amongst the best of the industry. 1ISRG outperforms 83.82% of its industry peers.
- The Return On Invested Capital of 1ISRG (12.45%) is better than 88.24% of its industry peers.
- 1ISRG had an Average Return On Invested Capital over the past 3 years of 10.15%. This is in line with the industry average of 9.73%.
- The last Return On Invested Capital (12.45%) for 1ISRG is above the 3 year average (10.15%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 12.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
- The Profit Margin of 1ISRG (28.58%) is better than 97.06% of its industry peers.
- 1ISRG's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 29.44%, 1ISRG belongs to the top of the industry, outperforming 98.53% of the companies in the same industry.
- 1ISRG's Operating Margin has declined in the last couple of years.
- 1ISRG has a better Gross Margin (66.38%) than 75.00% of its industry peers.
- 1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- 1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, 1ISRG has more shares outstanding
- The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
- There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.26
WACC9.88%
2.3 Liquidity
- A Current Ratio of 4.97 indicates that 1ISRG has no problem at all paying its short term obligations.
- 1ISRG has a Current ratio of 4.97. This is amongst the best in the industry. 1ISRG outperforms 97.06% of its industry peers.
- 1ISRG has a Quick Ratio of 4.20. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of 1ISRG (4.20) is better than 97.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 28.12% over the past year.
- The Earnings Per Share has been growing by 11.48% on average over the past years. This is quite good.
- Looking at the last year, 1ISRG shows a very strong growth in Revenue. The Revenue has grown by 22.18%.
- The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
- Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.67% on average per year.
- Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.12% on average per year.
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue Next Year21.32%
Revenue Next 2Y18.09%
Revenue Next 3Y16.5%
Revenue Next 5Y14.12%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 63.18, the valuation of 1ISRG can be described as expensive.
- Based on the Price/Earnings ratio, 1ISRG is valued a bit more expensive than 60.29% of the companies in the same industry.
- 1ISRG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
- Based on the Price/Forward Earnings ratio of 54.84, the valuation of 1ISRG can be described as expensive.
- 1ISRG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 72.06% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.31. 1ISRG is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.18 | ||
| Fwd PE | 54.84 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than 67.65% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ISRG is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.94 | ||
| EV/EBITDA | 53.49 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of 1ISRG may justify a higher PE ratio.
- 1ISRG's earnings are expected to grow with 15.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.14
PEG (5Y)5.5
EPS Next 2Y16.35%
EPS Next 3Y15.9%
5. Dividend
5.1 Amount
- No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1ISRG (1/15/2026, 7:00:00 PM)
468.2
-35 (-6.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-21 2025-10-21/amc
Earnings (Next)01-22 2026-01-22/amc
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap165.98B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts77
Price Target509.06 (8.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)-2.34%
PT rev (3m)-0.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.15%
EPS NY rev (1m)0.16%
EPS NY rev (3m)5.8%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)1.65%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.18 | ||
| Fwd PE | 54.84 | ||
| P/S | 20.07 | ||
| P/FCF | 84.94 | ||
| P/OCF | 65.17 | ||
| P/B | 11.32 | ||
| P/tB | 11.56 | ||
| EV/EBITDA | 53.49 |
EPS(TTM)7.41
EY1.58%
EPS(NY)8.54
Fwd EY1.82%
FCF(TTM)5.51
FCFY1.18%
OCF(TTM)7.18
OCFY1.53%
SpS23.33
BVpS41.36
TBVpS40.51
PEG (NY)3.14
PEG (5Y)5.5
Graham Number83.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 12.45% | ||
| ROICexc | 24.65% | ||
| ROICexgc | 25.69% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC9.88%
ROIC/WACC1.26
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.32%
Revenue Next 2Y18.09%
Revenue Next 3Y16.5%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year45.96%
EBIT Next 3Y24.75%
EBIT Next 5Y20.85%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 6 / 10 to 1ISRG.MI.
What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for 1ISRG stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 63.18 and the Price/Book (PB) ratio is 11.32.
Can you provide the financial health for 1ISRG stock?
The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.